Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1438.55
11.75 (0.82%) Cipla informs about press release
Date: 10-05-2021Cipla has informed that it has enclosed press release dated 10th May 2021 titled ‘Cipla Enters into a Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India’.
The above information is a part of company’s filings submitted to BSE.